Profil
Alexandre Mouradian is the founder of eureKARE SA, eureKING SA. He is currently the Chairman of Spinoza Foundation, Director of Stellate Therapeutics SAS, Director of Omne Possibile, and Director of Meletios Therapeutics SAS. He completed his undergraduate degree at ESCP Europe Campus Paris.
Postes actifs de Alexandre Mouradian
| Sociétés | Poste | Début |
|---|---|---|
eureKARE SA
eureKARE SA BiotechnologyHealth Technology Operates as biotechnology company for microbiome and synthetic biology | Directeur Général | - |
Meletios Therapeutics SAS
Meletios Therapeutics SAS BiotechnologyHealth Technology Operates as a biotechnology company that develops broad-spectrum therapeutic solutions | Directeur/Membre du Conseil | - |
eureKING SA
eureKING SA Financial ConglomeratesFinance Operates as a special purpose acquisition company | Fondateur | - |
Spinoza Foundation | Président | - |
Omne Possibile | Directeur/Membre du Conseil | - |
Stellate Therapeutics SAS
Stellate Therapeutics SAS BiotechnologyHealth Technology Develops innovative micro biome medicine for age related deceases | Directeur/Membre du Conseil | - |
Formation de Alexandre Mouradian
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 7 |
|---|---|
ESCP Europe Campus Paris
ESCP Europe Campus Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stellate Therapeutics SAS
Stellate Therapeutics SAS BiotechnologyHealth Technology Develops innovative micro biome medicine for age related deceases | Health Technology |
Omne Possibile | |
eureKARE SA
eureKARE SA BiotechnologyHealth Technology Operates as biotechnology company for microbiome and synthetic biology | Health Technology |
Meletios Therapeutics SAS
Meletios Therapeutics SAS BiotechnologyHealth Technology Operates as a biotechnology company that develops broad-spectrum therapeutic solutions | Health Technology |
eureKING SA
eureKING SA Financial ConglomeratesFinance Operates as a special purpose acquisition company | Finance |
Spinoza Foundation |
















